MedTrace Logo

Singapore COVID-19 Chemosensory Tracking (SCCT) Study

NCT04492904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2021-12-14

No results posted yet for this study

Summary

The study aims to longitudinally track the onset, severity and recovery of changes in chemosensory acuity (smell and/or taste loss) among those suspected of COVID-19 infection. Using standardised questionnaire and testing approaches, the investigators aim to objectively characterise and measure temporal changes in taste and smell to confirm the prevalence of these symptoms as an early marker of infection. Information on symptoms experience, changes in appetite and food-related quality of life will be also be assessed via questionnaire.

The results of the study will help individuals who experience a loss of smell and/or taste to self-isolate and/or self-refer to a medical professional, if an association between smell and/or taste and COVID-19 infection is found.

Conditions

  • Covid19

Interventions

OTHER

Home-use Test and Follow-up Questionnaire

Prospective tracking of changes in taste and smell acuity, and related changes in appetite, enjoyment of food and food-related quality of life will be assessed using the Home-use Tests and Follow-up questionnaire over a period of 28 days.

Sponsors & Collaborators

  • National University Hospital, Singapore

    collaborator OTHER

  • Singapore Institute of Food and Biotechnology Innovation

    lead OTHER_GOV

Principal Investigators

  • Ciaran Forde, Phd · Singapore Institute of Food and Biotechnology Innovation

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-17
Primary Completion
2021-06-15
Completion
2021-06-15

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04492904 on ClinicalTrials.gov